The Di Bella Method (DBM) in the treatment of prostate cancer: A preliminary retrospective study of 16 patients and a review of the literature

Giuseppe Di Bella, Fabrizio Mascia, Biagio Colori

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVE: To evaluate the objective clinical response and the safety of the combined administration of somatostatin, melatonin, retinoids, vitamin D3, dopamine subtype 2 receptor (D2R) agonists and low doses of cyclophosphamide, associated with androgen ablation, in patients with a histological diagnosis of prostate adenocarcinoma (Pac). MATERIALS AND METHODS: The clinical data of 30 patients with non-invasive and metastatic prostate cancer, who attended our institution over a period of more than 5 years, were retrospectively reviewed. RESULTS: 16 patients satisfied the evaluation criteria. Median age: 64 years. Disease stages: 8 patients (50%) were in Stage II. For advanced stages (Stage IV), secondary lesions were located in the bones and lymph nodes. Taken together, an overall objective response (OR) [Complete response (CR) + Partial Response (PR)] was achieved in 69% of the patients, with 88% of objective clinical benefit [CR+PR+SD]. For local Prostate Cancer group, an OR was achieved in 87.5% of patients (7 cases; 53-98; 95% CI), with CR in 62.5% (5 cases, 31-86; 95% CI). In metastatic disease, the OR was 50% (4 cases; 21-78; 95% CI), with a 20% of CR (2 cases; 7-59; 95% CI) and 75% of clinical benefit. CONCLUSIONS: This preliminary study shows that patients with early and advanced forms of prostate cancer, not previously treated by surgery and/or chemo-radiotherapy, can achieve a more than positive clinical benefit with the protocol foreseen by the Di Bella Method. Further clinical investigations are strongly recommended.

Original languageEnglish
Pages (from-to)523-528
Number of pages6
JournalNeuroendocrinology Letters
Volume34
Issue number6
Publication statusPublished - 2013

Keywords

  • Androgen deprivation
  • Bromocriptine
  • Cabergoline
  • Melatonin
  • Prostate cancer
  • Retinoids
  • Somatostatin/octreotide
  • Vitamins E, D3, C

ASJC Scopus subject areas

  • Endocrinology
  • Endocrine and Autonomic Systems
  • Endocrinology, Diabetes and Metabolism
  • Clinical Neurology
  • Psychiatry and Mental health
  • Neurology

Fingerprint Dive into the research topics of 'The Di Bella Method (DBM) in the treatment of prostate cancer: A preliminary retrospective study of 16 patients and a review of the literature'. Together they form a unique fingerprint.

Cite this